Omnis Health LLC – Trademark Portfolio
Entity Type: 16
Omnis Health LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include EVO, EMBRACE, EMBRACE EVO, EMBRACE PRO, and OMNIS HEALTH. The owner is based in Nashville, TN.
1309 Elm Hill Pike
Nashville, TN 37210
Showing of trademarks Trademarks
Trademark Classifications
Omnis Health LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Omnis Health LLC have?
Omnis Health LLC has 15 U.S. trademarks filed with the USPTO. Of these, 8 registered, 4 abandoned, 3 cancelled.
What trademark classes does Omnis Health LLC file in?
Omnis Health LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Omnis Health LLC's most well-known trademarks?
Omnis Health LLC's registered trademark portfolio includes well-known marks such as EVO, EMBRACE, EMBRACE EVO, EMBRACE PRO, and OMNIS HEALTH. These are among 8 currently registered trademarks in the portfolio.
What is Omnis Health LLC's trademark registration success rate?
Omnis Health LLC has a 53% trademark registration rate, with 8 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.